Nutrition Capital Network (NCN), the leading U.S. gateway for connections between investors and companies in the nutrition and health and wellness industry, is launching its inaugural European investor meeting on May 5, 2014, in Geneva, Switzerland. The meeting will be held in association with Vitafoods Europe, the leading ingredients and raw materials event for the nutraceutical, dietary supplements and functional food and drinks industries in Europe.
Since being founded in 2007, NCN has hosted 19 Investor Meetings in the United States and established a successful track record of matching growth companies and technology innovators with investors, acquirers and strategic partners: 166 of the 343 companies that have presented at NCN meetings have found financing or completed a transaction.
“NCN investor meetings have from the beginning attracted interest from the international investment community and from entrepreneurs and growth companies outside the United States,” said Grant Ferrier, president of NCN. “Interest in nutrition and health and wellness is a global trend; given the consistent quality and volume of deal flow we have seen over the last several years, we believe this is a good time to expand our network into Europe.”
With top companies like BASF, Bayer, Cargill, Coca-Cola, DSM, DuPont, Hershey’s, Kellogg’s, Pepsi, Tate & Lyle and Unilever among its distinguished Cornerstone Investors, NCN already has a global footprint.
At NCN Europe, selected NCN Cornerstone Investors will be joined by European-based strategic players and private equity investors with an eye on opportunities in European markets. Cornerstone Investors sponsoring NCN Europe will include Abbott Labs, DSM, Herbalife, Kerry Group, Seventure and Tate & Lyle Ventures. The Cornerstone Investors will co-host a cocktail reception after the noon to 6 p.m. May 5 meeting.
NCN Europe to focus on science, ingredients and technology
NCN Europe will focus on science, ingredients and technology related to nutrition and health and wellness. Finished product companies in consumer health, supplements or functional and natural and organic foods will also be considered as presenters. Presenting companies will be seeking investment, acquisition, or corporate partnerships for technology development, commercialization, clinical trials, distribution or licensing. Between 8 and 12 companies will present their business to an audience of 30 to 40 investors, with an opportunity for one-on-one meetings after the presentations.
“We’re pleased to be associated with Vitafoods, the biggest nutritional ingredients trade show in Europe. It provides an ideal context for NCN to present growth companies and their innovative technologies, selected and coached by our selection committee, to a European investor audience,” said Ferrier, who will chair the meeting.
Scheduled for Monday, May 5, 2014, from noon to 6 p.m., the half-day meeting will take place immediately prior to the Vitafoods Europe exhibition and conference, which runs May 6 to 8, 2014. NCN is an independent company that exists for the benefit of its members; it takes no fees associated with any transactions that result from its meetings.
Companies invited to apply to be a presenting company
Nutrition Capital Network is now accepting applications from companies interested in presenting their business plans at NCN Europe. Applying is free, but accepted presenters pay a €1,000 fee that includes business plan and presentation review by one or more of NCN’s selection committee mentors, introduction to multiple attendees at the meeting and key investors, and follow up. Start the free application process at nutritioncapital.com/Apply_for_NCN_at_Vitafoods_Europe.
Investors registered for NCN Europe must pay a €1,000 registration fee, which includes profiles of the presenting companies in advance of the meeting and complimentary floor badges for the Vitafoods Europe exhibition (May 6 to 8), in addition to discounts to selected VitaFoods conference sessions. For details go to nutritioncapital.com/NCN_Investor_Meeting_Vitafoods_Europe.
To register for NCN Europe investors should contact Grant Ferrier or NCN Executive Director Mike Dovbish at (415) 254-1116 or email [email protected]